Search for: "RISING PHARMACEUTICALS, INC."
Results 61 - 80
of 465
Sorted by Relevance
|
Sort by Date
23 Mar 2011, 7:50 am
Yesterday the Supreme Court handed down their opinion in the Zicam related securities fraud class action, Matrixx Initiatives, Inc. v. [read post]
30 Sep 2019, 6:08 am
In a letter seen by Reuters, the groups noted that the deal would create the fourth largest pharmaceutical company at a time when rising drug prices have become a hot political issue. [read post]
6 Mar 2018, 2:10 pm
In closing this article, I will point out that as of today, nearly five years after the actions taken by Novartis Pharmaceuticals Canada Inc., in the US there still has not been any "Dear Doctor" letter nor any Tasigna drug label change made by Novartis Pharmaceuticals Corporation similar to what was done in Canada during April 2013. [read post]
2 Jan 2008, 9:05 pm
Colony Pharmaceuticals, Inc. et al Wyeth v. [read post]
19 Apr 2021, 9:37 am
The sector’s biggest-ever deal comes as insurers grapple with rising claims and new challenges brought on by the COVID-19 pandemic and climate change. [read post]
26 Mar 2015, 7:55 am
When the curtain rose for oral argument in Omnicare, Inc. v. [read post]
8 Jan 2009, 12:32 pm
First DataBank, Inc., 244 F.R.D. 79 (D. [read post]
1 May 2023, 10:11 am
Teva Pharmaceuticals USA, Inc. v. [read post]
11 May 2016, 1:04 am
Intellectual Property Challenges in the Bio-Pharmaceutical Field Mike Mireles ponders whether the result of the upcoming presidential election may set the stage for substantial changes to the bio-pharmaceutical industry, says we are coming to a critical policy choice soon concerning whether to continue to further regulate the price of pharmaceuticals or continue to allow bio-pharmaceutical companies to control pricing. [read post]
15 Feb 2016, 4:00 am
Computer and Internet Weekly Updates for 2016-02-13 https://t.co/rzO2XdxDnf -> Inspection of property granted in copyright case Strathearn Consulting Inc. v. [read post]
21 Nov 2012, 11:32 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
10 Jun 2013, 9:30 pm
Watson Pharmaceuticals, Inc, a case raising the question of the legality of these agreements. [read post]
28 Nov 2012, 5:13 pm
Manufactured by Bayer Healthcare Pharmaceuticals, Inc., Mirena is an IUD device [intrauterine device] that must be inserted by a trained health care provider and is intended to provide contraceptive protection for up to five years. [read post]
28 Feb 2014, 9:27 pm
(Hereinafter “Janssen”); (2) Johnson & Johnson; (3) Johnson & Johnson Pharmaceutical Research & Development, L.L.C; (4) Excerpta Medica Inc.; and (5) Elsevier Inc. [read post]
24 Mar 2011, 5:10 am
After a long string of rebukes from the Court, the Ninth Circuit finally got an affirmance on Tuesday, in Matrixx Initiatives, Inc. v. [read post]
25 Mar 2010, 1:43 pm
In Ariad Pharmaceuticals, Inc. v. [read post]
10 Jul 2016, 10:00 pm
OEA, Inc., 270 F.3d 1353 (Fed. [read post]
6 Mar 2018, 2:10 pm
We are doing this review because it was during April 2013 that Novartis Pharmaceuticals Canada Inc. took these actions: Sent a so-called "Dear Doctor" letter in Canada (but not the US) warning about some serious side effects associated with Tasigna; and, Issued a Tasigna drug label change in Canada (but not the US) with new information concerning those Tasigna side effects. [read post]
21 Oct 2016, 7:47 am
According to DOJ’s press release: The nation’s largest nursing home pharmacy, Omnicare Inc., has agreed to pay $28.125 million to resolve allegations that it solicited and received kickbacks from pharmaceutical manufacturer Abbott Laboratories in exchange for promoting the prescription drug, Depakote, for nursing home patients. [read post]
11 Jul 2010, 5:18 pm
©2010 Amaxx Risk Solutions, Inc. [read post]
